Beligas PharmaTesamorelin 2 mg
| Quantity | Discount | Price |
|---|---|---|
| 3–5 | 10% | $36,00 |
| 6–9 | 15% | $34,00 |
| 10–100 | 20% | $32,00 |
Specifications
- Brand: Beligas Pharma HGH, Peptides & SARMs
- Substance: Tesamorelin
- Product Form: Powder
- Dosage: 2 mg
How To Use
Laboratory Reconstitution & Research Dosing Protocols
Disclaimer: The following information is for educational and laboratory reference only. This product is strictly for in-vitro and in-vivo research and is not intended for human consumption or therapeutic use.
This vial contains 2 mg (2,000 mcg) of lyophilized Tesamorelin powder. Maintaining peptide stability through proper handling is critical for data accuracy.
Reconstitution Guide
For standard research concentration, reconstitute the 2 mg vial with 1 ml of Bacteriostatic Water or Sterile Saline.
- Preparation: Slowly inject 1 ml of water against the glass wall of the vial.
- Dissolution: Swirl gently until clear. Do not shake, as the 44-amino acid structure is delicate.
- Measurement Reference (Using 1 ml dilution):
- 25 Units (0.25 ml) = 500 mcg
- 50 Units (0.50 ml) = 1,000 mcg (1 mg)
Storage Specifications
- Unmixed (Lyophilized): Store in a cool, dry place. For long-term preservation, store at -20°C.
- Mixed (Reconstituted): Must be refrigerated (2°C to 8°C). Use within 7-10 days for maximum analytical integrity.
Experience Level Usage Guide
Beginner
Baseline Metabolic Signaling
Reference dosing for initial studies investigating pulsatile GH release and acute tolerance.
- Test Subject Dosage: 500 mcg to 1,000 mcg per administration.
- Frequency: Administered once daily (typically prior to the rest cycle).
- Observation Period: 30 days.
Intermediate
Targeted Adipose Research
Standard dosage for evaluating visceral fat reduction and lipid metabolic shifts.
- Test Subject Dosage: 2 mg (full vial) daily.
- Frequency: Once daily administration.
- Observation Period: 8 to 12 weeks.
Advanced
Advanced Somatotropic Stack
Advanced protocol investigating the synergy between GHRH stimulation and Ghrelin receptor agonism.
- The Stack: Tesamorelin (1 mg) + Ipamorelin (200 mcg).
- Scientific Rationale: Investigates the synergy between full-length GHRH agonism (Tesamorelin) and selective GHS agonism (Ipamorelin) to maximize endogenous GH pulses while maintaining glycemic control.
- Frequency: Once daily administration for longitudinal data collection.
Shipping Details
Detailed Description
What Is Beligas Pharma Tesamorelin 2 mg?
Beligas Pharma Tesamorelin 2 mg is a potent synthetic analog of the Growth Hormone Releasing Hormone (GHRH). In clinical and laboratory research, it is specifically recognized for its unique ability to target visceral adipose tissue. This 2 mg formulation is a primary tool for researchers investigating the reduction of deep abdominal fat, the optimization of metabolic profiles, and the stimulation of endogenous growth hormone pulses without affecting glucose homeostasis as aggressively as other analogs.
If your research goals involve investigating advanced lipolysis or metabolic syndrome modeling, you can buy peptides of this high-grade quality through our Metabolic & Fat Loss Peptides category.
Important: Beligas Pharma Tesamorelin 2 mg is strictly for laboratory research and is not intended for human consumption or therapeutic use.
Beligas Pharma Tesamorelin 2 mg: Technical Profile
| Scientific Parameter | Details for Beligas Pharma Tesamorelin |
|---|---|
| Peptide Type | GHRH (Growth Hormone Releasing Hormone) Analog |
| Vial Concentration | 2 mg Lyophilized Powder |
| Purity Level | >99% (HPLC Verified) |
| Primary Focus | Visceral Adipose Tissue (VAT) Reduction |
Research Benefits of Beligas Pharma Tesamorelin 2 mg
In controlled laboratory settings, Tesamorelin 2 mg is valued for its specific affinity for metabolic repair. Key research benefits include:
- Targeted Lipolysis: Studying the peptide’s superior ability to reduce visceral fat compared to subcutaneous fat.
- Endogenous GH Stimulation: Investigating how it signals the pituitary gland to release growth hormone in a natural, pulsatile manner.
- Lipid Profile Optimization: Researching the improvement of triglyceride and cholesterol levels in metabolic research models.
- Growth Synergy: Exploring how order HGH or GHRP protocols might interact with Tesamorelin to enhance total tissue regeneration.
How Does Beligas Pharma Tesamorelin 2 mg Work?
The mechanism of Tesamorelin 2 mg involves binding to and activating GHRH receptors in the pituitary gland. This triggers the synthesis and release of natural growth hormone, which subsequently increases IGF-1 levels. Because Peptidesline ensures that each Beligas vial is vacuum-sealed and analytical-grade, researchers can observe these metabolic shifts—specifically the breakdown of difficult visceral fat—with high precision and experimental consistency.
Potential Side Effects of Tesamorelin in Research Models
When administering in laboratory subjects, researchers should monitor for the following dose-dependent responses:
- Arthralgia & Myalgia: Studies often note observed joint or muscle stiffness in research subjects during high-dose protocols.
- Injection Site Sensitivity: Potential localized redness or irritation at the administration point.
- Fluid Dynamics: Researchers frequently monitor for transient peripheral edema (water retention).
- Glucose Variance: While generally safer for blood sugar than direct HGH, researchers still track insulin sensitivity in long-term models.
Can Tesamorelin vs. Other Metabolic Peptides be stacked?
Yes. The most famous stack is Tesamorelin + Ipamorelin. While Tesamorelin stimulates the release of GH, Ipamorelin inhibits somatostatin (the hormone that stops GH release). Together, they create a massive synergistic pulse of growth hormone for maximum fat burning.
| Research Peptide | Primary Mechanism | Main Research Strength |
|---|---|---|
| CJC-1295 (No DAC) | GHRH Analog | Short-burst GH release for general repair. |
| Fragment 176-191 | GH Lipolytic Fragment | Pure fat loss without affecting GH levels. |
| Tirzepatide | GLP-1/GIP Agonist | Appetite suppression and glycemic control. |
| Tesamorelin 2 mg | GHRH (VAT Selective) | Reduction of stubborn visceral abdominal fat. |
Buy Beligas Pharma Tesamorelin Peptides Online USA
When conducting critical metabolic or lipolysis research, Peptidesline is your reliable source for batch-certified compounds. Our Tesamorelin 2 mg is vacuum-sealed and HPLC-verified for 100% integrity.
- Express USA Delivery: Shipped directly to your facility in 4-7 business days.
- Secure Payment: Simple checkout options via Zelle or Venmo.
- 10% Crypto Discount: Unlock a 10% discount on Tesamorelin 2 mg by paying with Bitcoin or USDT at checkout.
- Click here for Payment Options
FAQ
It is researched for its specific ability to stimulate growth hormone release and target the reduction of visceral adipose tissue (abdominal fat) in laboratory models.
Tesamorelin stimulates natural GH production from the pituitary, whereas Fragment 176-191 only mimics the fat-burning portion of HGH without affecting hormone levels.
Dry vials should be frozen. Once reconstituted, store strictly in the refrigerator at 2-8°C and utilize within 25 days for maximum potency.
Yes. Peptidesline provides analytical-grade products with verifiable batch numbers to ensure researchers receive >99% pure compounds.
We ensure your research tools reach your laboratory in 4-7 business days via express, temperature-monitored shipping channels.
